Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • c-Met/HGFR
    (10)
  • VEGFR
    (2)
  • c-Kit
    (2)
  • EGFR
    (1)
  • FLT
    (1)
  • Phospholipase
    (1)
  • ROR
    (1)
  • Src
    (1)
  • TAM Receptor
    (1)
  • c-Fms
    (1)
Filter
Search Result
Results for "

cmet inhibitor 1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    10
    TargetMol | Inhibitors_Agonists
c-Met inhibitor 1
T106551357072-61-7
c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of cancer including glioblastoma, gastric, and pancreatic cancer.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
RPI-1
T2282269730-03-2
RPI-1 is a competitive, potent ATP-dependent Ret kinase inhibitor.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
c-Kit-IN-1
PDGFR inhibitor 1, DCC-2618
T43321225278-16-9
c-Kit-IN-1 (DCC-2618) is an effective inhibitor of c-Met and c-Kit (IC50s<200 nM).
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
SYN1143
RON-IN-1, AMG-1
T8409913376-84-8
SYN1143 (AMG-1) is a potent inhibitor of human RON and c-Met.In vitro kinase assays showed that compound I is a potent inhibitor of human RON and c-Met with IC50s of 9 and 4 nmol L, respectively.
  • Inquiry Price
7-10 days
Size
QTY
TargetMol | Inhibitor Sale
EGFR-IN-8
T111622407957-87-1
EGFR-IN-8, a dual inhibitor targeting both EGFR and c-Met, shows potential as a promising candidate for further development in treating EGFR TKI-resistant NSCLC.
  • Inquiry Price
8-10 weeks
Size
QTY
TargetMol | Inhibitor Sale
CSF1R-IN-2
T131942271119-26-5
CSF1R-IN-2 is an oral-active SRC, MET and c-FMS inhibitor (IC50s: 0.12 nM, 0.14 nM and 0.76 nM for SRC, MET and c-FMS respectively).
  • Inquiry Price
Size
QTY
JNJ-38877618
OMO-1
T15617943540-74-7
JNJ-38877618 (OMO-1) is an effective and highly selective inhibitor of Met kinase (IC50s: 2 and 3 nM for wild type and mutant Met, respectively).
  • Inquiry Price
Size
QTY
Cabozantinib hydrochloride
XL184, Cabozantinib hydrochloride (849217-68-1(free base)), BMS-907351
T51641817759-42-4
Cabozantinib hydrochloride (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, and Flt4 (IC50s: 0.035, 1.3, 4.6, 7 and 6 nM).
  • Inquiry Price
Size
QTY
SCR-1481B1
c-Met inhibitor 2
T53491174161-86-4
SCR-1481B1 (c-Met inhibitor 2) has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor
  • Inquiry Price
Size
QTY
MK-8033
TQ02191001917-37-8
MK-8033 is a new and selective dual ATP competitive c-Met Ron inhibitor (IC50: 1 nM Wt c-Met).
  • Inquiry Price
Size
QTY